eNOS Mediates TO90317 Treatment-Induced Angiogenesis and Functional Outcome After Stroke in Mice
- 1 July 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 40 (7) , 2532-2538
Abstract
Background and Purpose— TO901317, a synthetic liver X receptor agonist, elevates high-density lipoprotein cholesterol (HDL-C) in mice. We tested the hypothesis that TO901317 treatment of stroke promotes angiogenesis and vascular maturation and improves functional outcome after stroke by increasing endothelial nitric oxide synthase (eNOS) phosphorylation. Methods— C57BL/6J mice were subjected to middle cerebral artery occlusion and were treated with or without TO901317 (30 mg/kg) starting 24 hours after middle cerebral artery occlusion and daily for 14 days. Results— TO901317 significantly increased serum HDL-C level, promoted angiogenesis and vascular stabilization in the ischemic brain, and improved functional outcome after stroke. The increased HDL-C level significantly correlated with functional recovery after stroke. TO901317 also increased eNOS phosphorylation in the ischemic brain. Mechanisms underlying the TO901317-induced angiogenesis were investigated using eNOS knockout (eNOS−/−) mice. TO901317 treatment of eNOS−/− mice significantly increased HDL-C level but failed to increase angiogenesis and functional outcome after stroke. In vitro studies demonstrated that TO901317 and HDL-C significantly increased capillary tube formation and promoted eNOS phosphorylation activity in cultured mouse brain endothelial cells compared with nontreatment controls. However, TO901317 and high-density lipoprotein treatment-induced capillary tube formation were absent in eNOS-deficient mouse brain endothelial cell. Conclusions— These data indicate that TO901317 treatment increases serum HDL-C level, which promotes angiogenesis through eNOS and leads to improvement of functional outcome after stroke.Keywords
This publication has 38 references indexed in Scilit:
- LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanismsJournal of Lipid Research, 2009
- Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental StrokeCirculation, 2008
- Treatment with LXR agonists after focal cerebral ischemia prevents brain damageFEBS Letters, 2008
- Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From StrokeStroke, 2007
- Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat*1Cardiovascular Research, 2004
- Phospholipid Transfer Protein Is Regulated by Liver X Receptors in VivoJournal of Biological Chemistry, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Neuronal Damage and Plasticity Identified by Microtubule-Associated Protein 2, Growth-Associated Protein 43, and Cyclin D1 Immunoreactivity After Focal Cerebral Ischemia in RatsStroke, 1998
- Seizures and recovery from experimental brain damageExperimental Neurology, 1988